The following publications are possibly variants of this publication:
- Discovery of Novel Pim-1 Kinase Inhibitors with a Flexible-Receptor Docking ProtocolGudong Li, Wei Li, Yuting Xie, Xiaobo Wan, Guojun Zheng, Niu Huang, Yu Zhou. jcisd, 59(10):4116-4119, 2019. [doi]
- Virtual screening of B-Raf kinase inhibitors: A combination of pharmacophore modelling, molecular docking, 3D-QSAR model and binding free energy calculation studiesWen Zhang, Kai-Xiong Qiu, Fang Yu, Xiao-Guang Xie, Shuqun Zhang, Ya-Juan Chen, Hui-Ding Xie. CANDC, 70:186-190, 2017. [doi]
- Discovery of Novel Inhibitors Targeting the Menin-Mixed Lineage Leukemia Interface Using Pharmacophore- and Docking-Based Virtual ScreeningYuan Xu, Liyan Yue, Yulan Wang, Jing Xing, Zhifeng Chen, Zhe Shi, Rongfeng Liu, Yu-Chih Liu, Xiaomin Luo, Hualiang Jiang, Kaixian Chen, Cheng Luo, Mingyue Zheng. jcisd, 56(9):1847-1855, 2016. [doi]
- Developing new PI3Kγ inhibitors by combining pharmacophore modeling, molecular dynamic simulation, molecular docking, fragment-based drug design, and virtual screeningJingyu Zhu, Dan Sun, Xintong Li, Lei Jia, Yanfei Cai, Yun Chen, Jian Jin, Li Yu. CANDC, 104:107879, June 2023. [doi]